H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

14 January 2022 : Database Analysis

Zongkuo Li^12AE, Menglong Hu^12A, Jinhuan Qiu^12C, Junkai Feng^12C, Ruizhen Zhang^1C, Huifang Wu^1D, Guiming Hu^1D, Jingli Ren^1G*

DOI: 10.12659/MSM.933447

Med Sci Monit 2022; 28:e933447

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Association between H2AFZ expression and clinicopathological characteristics in patients with LUAD in our cohort.

Characteristics	H2AFZ expression		Total	p Value
Characteristics	Low (n=220)	High (n=219)	Total	p Value
Age
<65	29	51	80	0.865
≥65	10	19	29	0.865
Gender
Male	14	40	54
Female	25	30	55
Pathological stage
I	25	36	61
II	5	23	28
III	8	6	14
IV	1	5	6
T classification
T1	23	45	68	0.801
T2	10	18	28
T3	5	5	10
T4	1	2	3
N classification
N0	23	41	64	0.679
N1	4	11	15
N2	12	18	30
N3
Bold values indicate

Back to the Article